SEC Contract Filing

Filing Date: 2021-06-29

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>tm2120803d3_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSCRIPTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This SUBSCRIPTION AGREEMENT
(this &ldquo;<U>Subscription Agreemen</U>t&rdquo;) is entered into on June&nbsp;28, 2021, by and between DFP Healthcare Acquisitions Corp.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the undersigned subscribers (each a &ldquo;<U>Subscriber</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, concurrently with
the execution of this Subscription Agreement, the Company is entering into a definitive agreement with TOI Parent,&nbsp;Inc., a Delaware
corporation (&ldquo;<U>TOI</U>&rdquo;) and certain other parties thereto, in substantially the form provided to Subscriber prior to the
date hereof, providing for the acquisition by the Company of all of the issued and outstanding equity interests of TOI (the &ldquo;<U>Transaction
Agreemen</U>t&rdquo; and the transactions contemplated by the Transaction Agreement, the &ldquo;<U>Transaction</U>&rdquo;)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the Transaction, Subscriber desires to subscribe for and purchase from the Company, immediately prior to the consummation of the Transaction,
that number of shares of the Company&rsquo;s Class&nbsp;A Common Stock, par value $0.0001 per share (the &ldquo;<U>Class&nbsp;A Common
Stock</U>&rdquo;), set forth on the signature page&nbsp;hereto (the &ldquo;<U>Subscribed Common Shares</U>&rdquo;) for a purchase price
of $10.00 per share (the &ldquo;<U>Per Common Share Price</U>&rdquo;), and the Company desires to issue and sell to Subscriber the Subscribed
Shares in consideration of the payment of the Purchase Price by or on behalf of Subscriber to the Company&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Subscriber and
the Company have entered into a letter agreement on even date herewith (the &ldquo;<U>Consent Letter</U>&rdquo;), pursuant to which, among
other things, the Subscriber and the other investors party thereto (collectively, &ldquo;<U>Deerfield Investors</U>&rdquo;) and the Company
have agreed to use their reasonable best efforts to establish definitive documentation pursuant to which the Deerfield Investors will
exchange a number of their shares of Company&rsquo;s Class&nbsp;A Common Stock and the Company&rsquo;s Class&nbsp;B Common Stock, for
and in consideration of, a number of shares of the Company&rsquo;s Preferred Stock, to be designated as Series&nbsp;A Common Equivalent
Preferred Stock, pursuant to the terms of the Certificate of Designation, Preferences and Rights contemplated by the Consent Letter (the
 &ldquo;<U>Certificate of Designation</U>&rdquo;), on a 100:1 basis (the &ldquo;<U>Pre-Closing Exchange</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, if the Pre-Closing
Exchange is being consummated, on the Closing Date Subscriber will subscribe for and purchase from the Company, and the Company will issue
and sell to Subscriber a number shares of Series&nbsp;A Common Equivalent Preferred Stock (the &ldquo;<U>Subscribed Common Equivalent
Preferred Shares</U>&rdquo; and, together with the Subscribed Common Shares, the &ldquo;<U>Subscribed Shares</U>&rdquo;) convertible into
the number of Subscribed Shares set forth on the signature page&nbsp;hereto (or such lesser number as Subscriber may designate in writing
prior to the Closing Date) for a purchase price of $1,000 per share (the &ldquo;<U>Per Common Equivalent Preferred Share Price</U>&rdquo;
and the aggregate of the Per Common Share Purchase Price for all Common Subscribed Shares and the Per Common Equivalent Preferred Share
Purchase Price for all Subscribed Common Equivalent Preferred Shares being referred to as the &ldquo;<U>Purchase Price</U>&rdquo;) and
the number of shares of Company Class&nbsp;A Common Stock subscribed for hereunder will be reduced by an amount corresponding to the number
of shares of Company Class&nbsp;A Common Stock into which the Subscribed Common Equivalent Preferred Shares are convertible (such shares
of Class&nbsp;A Common Stock referred to herein as the &ldquo;<U>Conversion Shares</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the Transaction, the Company and the Subscriber will enter into the Amended and Restated Registration Rights Agreement, in the form attached
hereto as Exhibit&nbsp;A (the &ldquo;<U>Registration Rights Agreement</U>&rdquo; and, together with this Subscription Agreement, the &ldquo;<U>Subscription
Documents</U>&rdquo;), superseding that certain Registration Rights Agreement, dated as March&nbsp;10, 2020, by and among the Company,
DFP Sponsor LLC and the other parties thereto; and</P>

<P STYLE="font: